You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 5, August 6, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Violence and Human Rights
 •Bioterrorism
 •War
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bronchiolitis Obliterans in a Survivor of a Chemical Weapons Attack

To the Editor: Bronchiolitis obliterans develops when an injury of small conducting airways leads to the proliferation of granulation tissue and obliteration of the airway lumen. The histological pattern is nonspecific and can result from multiple etiologies. The clinical presentation is divided into 5 categories: toxic fume inhalation, postinfectious, connective tissue disease–associated, localized, and idiopathic.1 Several substances have been reported to cause bronchiolitis obliterans through inhalation of toxic fumes. The distribution of these agents in the lung is determined by the size of the molecule, the duration of exposure, and the solubility of the agent.2

The inhalation of mustard gas has been reported to cause chronic bronchitis, airway hyperactivity, bronchiectasis, and pulmonary fibrosis,3-6 but there are no reports of the occurrence of bronchiolitis obliterans. We report a patient with confirmed bronchiolitis obliterans several years after likely exposure to mustard gas in Iraq.

Report of a Case

In August 2001, we evaluated a 37-year-old male Iraqi Kurd for possible lung transplantation. He reported that he had been present on March 16, 1988, when Iraqi fighter jets dropped multiple warheads on the northeastern Iraqi city of Halabja. (The Halabja attack has been extensively documented elsewhere.7-8) He and his family initially feared direct physical harm and fled to the basement of their home, but oppressive heat and poor air circulation forced them from this enclosed space. As they ran outside, the patient noted a noxious odor similar to rotten fruit. He reported that the intense smell lasted for 5 hours, during which time 15 members of the patient's family died on the street.

Six hours after his initial exposure, our patient reported experiencing eye pain, copious tearing, cough, and dyspnea. He then developed complete blindness, a condition that lasted for 20 days. The Red Crescent service of Iran transported him to the United States for ophthalmologic care and he recovered with treatment (records unavailable). His cough, dyspnea, and production of sputum progressed over the next 14 years, eventually limiting his ability to perform activities of daily living. The patient reported that his parents also complain of similar but less severe lung-related symptoms, including the daily production of purulent sputum. Neither the patient nor any members of his family have any history of tobacco use. He denied having had a history of pneumonia or significant occupational or environmental exposures before 1988.

The patient's ambulatory room air oxygen saturation was 87%. Pertinent physical findings included decreased bilateral breath sounds and an increased anteroposterior diameter. A posterior-anterior chest radiograph displayed hyperinflation and basilar bullae (Figure 1), and pulmonary function testing revealed a severe obstructive pattern with no airflow reversibility. There was no evidence of a connective tissue disorder or {alpha}1-antitrypsin deficiency on laboratory evaluation. Subsequent studies included a high-resolution computed tomography scan of his chest (Figure 2) and transbronchial lung biopsies (Figure 3), which revealed bronchiolitis obliterans.



View larger version (72K):
[in this window]
[in a new window]
Figure 1. Posterior-Anterior Chest Radiograph of Patient With Bronchiolitis Obliterans

Radiograph shows hyperinflation and basilar bullae.




View larger version (76K):
[in this window]
[in a new window]
Figure 2. Computed Tomography Scan of the Chest of Patient With Bronchiolitis Obliterans

Scan performed using intravenous contrast demonstrates a ground-glass, mosaic pattern with sharply demarcated borders and surrounding hypodense pulmonary parenchyma, consistent with small airway disease.




View larger version (131K):
[in this window]
[in a new window]
Figure 3. Transbronchial Lung Biopsy Specimen From Patient With Bronchiolitis Obliterans

Low-power view showing 2 obliterated airways, one with chronic inflammatory infiltrate (black arrowhead) and one with fibrosis alone (white arrowhead) (Mason Trichrome stain, original magnification x25).


Treatment included high doses of prednisone (1 mg/kg of body weight) for 6 months, followed by tapering to his current dose of 10 mg/d.9 His symptoms have substantially improved, his spirometry remains stable, and he has not yet required listing for lung transplantation.


Comment

Investigations have revealed that mustard gas and the nerve gases sarin, VX, and Tabun were used in the Halabja attack.7-8 Mustard gas is a vesicant that damages cells through alkylation of DNA and through a secondary, cytokine-mediated inflammatory response.10 This occurs at areas of contact between the gas and human tissue (ie, the eyes and respiratory tract). Eye pain, excessive lacrimation, and blindness occur within 1 to 12 hours of exposure, while edema of the tracheobronchial tree occurs between 4 and 12 hours. High concentrations induce pseudomembranous changes in the airways, and may result in airway necrosis. The clinical course is frequently complicated by secondary bacterial pneumonias. Our patient's initial ophthalmic and ongoing pulmonary symptoms are consistent with exposure to a vesicant such as mustard gas.

The majority of medical reports regarding exposure to mustard gas describe the respiratory symptoms of soldiers involved in various military conflicts, including World War I and the Iran-Iraq war.3-4,6 None of these reports, however, has described bronchiolitis obliterans resulting from exposure to mustard gas or among civilian populations specifically targeted by chemical warfare. We suggest that bronchiolitis obliterans should be considered in patients with respiratory symptoms who have a history of possible exposure to mustard gas.

Funding/Support: This work was supported by grant HL 07123 from the National Heart, Lung, and Blood Institute, National Institutes of Health.

Acknowledgment: We thank Joyce Johnson, MD, and Stephen Dummer, MD.

Jason W. W. Thomason, MD; Todd W. Rice, MD; Aaron P. Milstone, MD
Division of Allergy, Pulmonary, and Critical Care Medicine
Vanderbilt University School of Medicine
Nashville, Tenn

1. Epler GR, Colby TV. The spectrum of bronchiolitis obliterans. Chest. 1983;83:161-162. FREE FULL TEXT
2. Greenfield RA, Brown BR, Hutchins JB. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. 2002;323:326-340. WEB OF SCIENCE | PUBMED
3. Bijani K, Moghadamnia AA. Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). Ecotoxicol Environ Saf. 2002;53:422-424. FULL TEXT | PUBMED
4. Emad A, Rezainan GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure. Chest. 1997;112:734-738. FREE FULL TEXT
5. Freitag L, Firusian N, Stamatis G. The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest. 1991;100:1436-1441. FREE FULL TEXT
6. Gilchrist HL, Matz PB. The residual effects of warfare gases: the use of phosgene gas, with report of cases. Med Bull Vet Adm. 1933;10:1-37.
7. Rubin J. US Statement on Twelfth Anniversary of the Halabja Massacre. 2000. Available at: http://www.usis.it/file2000_03/alia/a0031711.htm. Accessibility verified July 7, 2003.
8. Gosden CM. The 1988 chemical weapons attack on Halabja, Iraq. In: Alexander Y, Hoening M, eds. Super Terrorism: Biological, Chemical, and Nuclear. Ardsley, NY: Transnational Publishers Inc; 2001.
9. Lazarus SC. Disorders of intrathoracic airways. In: Murray J, Nadel J, eds. Textbook of Respiratory Medicine. 3rd ed. St Louis, Mo: WB Saunders Co; 2000.
10. Urbanetti JS. Battlefield chemical inhalation injury. In: Loke J, ed. Pathophysiology and Treatment of Inhalation Injuries. New York, NY: Marcel Dekker; 1998:281-346. Lung Biology in Health and Disease; vol 34.

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290:598-599.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Late respiratory effects of sulfur mustard: how is the early symptoms severity involved?
Ghanei et al.
Chronic Respiratory Disease 2008;5:95-100.
ABSTRACT  

Challenges in pulmonary fibrosis {middle dot} 2 : Bronchiolocentric fibrosis
Cordier
Thorax 2007;62:638-649.
ABSTRACT | FULL TEXT  

Occupational and Environmental "Orphan" Respiratory Diseases
Blanc
Am. J. Respir. Crit. Care Med. 2006;173:253-254.
FULL TEXT  

Tracheobronchomalacia and Air Trapping after Mustard Gas Exposure
Ghanei et al.
Am. J. Respir. Crit. Care Med. 2006;173:304-309.
ABSTRACT | FULL TEXT  

Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard
Aghanouri et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2004;287:L1160-L1164.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.